Cargando…

Mesorectal radiotherapy for early stage rectal cancer: A novel target volume

With the introduction of population-based bowel cancer screening, rectal cancer is diagnosed at earlier stages, yet standard treatment still requires the same extensive surgery that is used for more advanced stages. Organ preserving treatment is rapidly developing and is subject of investigation in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peters, Femke P., Teo, Mark T.W., Appelt, Ane L., Bach, Simon, Baatrup, Gunnar, de Wilt, Johannes H.W., Jensenius Kronborg, Camilla, Garm Spindler, Karen-Lise, Marijnen, Corrie A.M., Sebag-Montefiore, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031087/ https://www.ncbi.nlm.nih.gov/pubmed/32099912 http://dx.doi.org/10.1016/j.ctro.2020.02.001

Ejemplares similares

Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer – A multicentre dose planning study
por: Appelt, Ane L., et al.
Publicado: (2019)

Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study
por: Rombouts, Anouk J M, et al.
Publicado: (2017)

Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy
por: Truelsen, Christina Glismand, et al.
Publicado: (2022)

Pelvic Insufficiency Fractures and Bone Pain after Radiation Therapy for Anal Cancer: Relation to Pelvic Bone Dose-Volume Parameters
por: Kronborg, Camilla Jensenius, et al.
Publicado: (2022)

Patient-reported outcomes in PROSPECT trial (Alliance N1048) – FOLFOX is not a panacea
por: O'Cathail, Sean M., et al.
Publicado: (2023)

Radiotherapy for rectal cancer: Short course versus long course – When and how
por: Sebag-Montefiore, David
Publicado: (2013)

Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center
por: Ferenschild, Floris T. J., et al.
Publicado: (2009)

Estimated dose to site of loco-regional recurrence after radiotherapy in anal cancer using point of origin methods
por: Lycke Wind, Karen, et al.
Publicado: (2023)

Total mesorectal excision for the treatment of rectal cancer
por: Zedan, Ali, et al.
Publicado: (2015)

Time for a lead-time definition? Author response to ‘Why the length of recurrence free survival or “lead-times” can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis’
por: Spindler, Karen-Lise Garm, et al.
Publicado: (2023)

Robotic total mesorectal excision for the treatment of rectal cancer
por: Baik, Seung Hyuk, et al.
Publicado: (2007)

Update on Robotic Total Mesorectal Excision for Rectal Cancer
por: Giuratrabocchetta, Simona, et al.
Publicado: (2021)

International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic()
por: Marijnen, C.A.M., et al.
Publicado: (2020)

Can Ex Vivo Magnetic Resonance Imaging of Rectal Cancer Specimens Improve the Mesorectal Lymph Node Yield for Pathological Examination?
por: Stijns, Rutger, et al.
Publicado: (2019)

Urinary dysfunction in women following total mesorectal excision versus partial mesorectal excision for treatment of rectal cancer
por: Chill, Henry H., et al.
Publicado: (2021)

Prognostic factors for patients with anal cancer treated with conformal radiotherapy—a systematic review
por: Theophanous, Stelios, et al.
Publicado: (2022)

Voiding Dysfunction after Total Mesorectal Excision in Rectal Cancer
por: Kim, Jae Heon, et al.
Publicado: (2011)

Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision
por: Gilbert, Alexandra, et al.
Publicado: (2022)

Circulating tumor DNA: Response Evaluation Criteria in Solid Tumors – can we RECIST? Focus on colorectal cancer
por: Spindler, Karen-Lise Garm, et al.
Publicado: (2023)

Nonplatinum‐based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population‐based Danish anal cancer group study
por: Truelsen, Christina Glismand, et al.
Publicado: (2021)

A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer
por: Franco, Pierfrancesco, et al.
Publicado: (2022)

Impact of a diverting ileostomy in total mesorectal excision with primary anastomosis for rectal cancer
por: Hol, Jeroen C., et al.
Publicado: (2022)

Female urogenital dysfunction following total mesorectal excision for rectal cancer
por: Daniels, Ian R, et al.
Publicado: (2006)

Transumbilical laparoendoscopic single-site total mesorectal excision for rectal carcinoma
por: Michalik, Maciej, et al.
Publicado: (2012)

Transanal Total Mesorectal Excision With Single-Incision Laparoscopy for Rectal Cancer
por: Foo, Dominic Chi-chung, et al.
Publicado: (2016)

Transanal Total Mesorectal Excision for Rectal Cancer: Perioperative and Oncological Outcomes
por: Hur, Hyuk
Publicado: (2018)

From Total Mesorectal Excision to Organ Preservation for the Treatment of Rectal Cancer
por: Baek, Seong Kyu
Publicado: (2019)

Comparing outcomes of robotic versus open mesorectal excision for rectal cancer
por: Jimenez-Rodriguez, Rosa M, et al.
Publicado: (2022)

Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer
por: Maykel, Justin A., et al.
Publicado: (2022)

Association of Transanal Total Mesorectal Excision With Local Recurrence of Rectal Cancer
por: Caycedo-Marulanda, Antonio, et al.
Publicado: (2021)

Learning Curve of Robotic-Assisted Total Mesorectal Excision for Rectal Cancer
por: Tang, Bo, et al.
Publicado: (2022)

Oncological monitoring after transanal total mesorectal excision for rectal neoplasia
por: Gachabayov, M., et al.
Publicado: (2023)

Oncological outcomes after transanal total mesorectal excision for rectal cancer
por: Francis, Nader K, et al.
Publicado: (2023)

A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial
por: Hudson, Eleanor M, et al.
Publicado: (2022)

Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020
por: Hanna, C.R., et al.
Publicado: (2021)

Benchmarking daily adaptation using fully automated radiotherapy treatment plan optimization for rectal cancer
por: Jagt, Thyrza Z., et al.
Publicado: (2022)

Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer
por: Craven, I, et al.
Publicado: (2007)

T(1ρ) for Radiotherapy Treatment Response Monitoring in Rectal Cancer Patients: A Pilot Study
por: Kooreman, Ernst S., et al.
Publicado: (2022)

Effect of intrafraction adaptation on PTV margins for MRI guided online adaptive radiotherapy for rectal cancer
por: Kensen, Chavelli M., et al.
Publicado: (2022)

Online Adaptive MRI-Guided Radiotherapy for Primary Tumor and Lymph Node Boosting in Rectal Cancer
por: Kensen, Chavelli M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u14eoc8fgmppb5qiqk2vumm73d